JACC This Week · American College of Cardiology

Heart Failure Insights, AI Standards, and Genetic Clues | JACC This Week

·15 min·1 clip

Why did patients on terzepatide see similar heart benefits despite less weight loss in the SUMMIT trial?

This episode of JACC This Week covers recent cardiovascular research, including AI standards for submissions, terzepatide's effects in heart failure with preserved ejection fraction, racial disparities in hospitalization ages, genetic variants in atrial fibrillation, and the burden of heart failure in Japan's elderly population. Host Harlan Krumholz provides insights and editorial context on these studies.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from JACC This Week